Brooklyn Stock Valuation


USD 0.52  0.01  1.89%   

Do you wonder what the value of Brooklyn Immunotherapeuti is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Brooklyn Immunotherapeuti, is its stock price multiplied by the total number of shares outstanding, calculating Brooklyn Immunotherapeuti's enterprise value requires a different approach. It uses Brooklyn Immunotherapeuti's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Enterprise Value is likely to rise to about 211.3 M in 2022, whereas Free Cash Flow is likely to drop (24.3 M) in 2022.
Brooklyn Immunotherapeuti shows a prevailing Real Value of $4.01 per share. The current price of the firm is $0.52. Brooklyn Immunotherapeuti is undervalued. Our model approximates the value of Brooklyn Immunotherapeuti from analyzing the firm fundamentals such as Shares Owned by Institutions of 32.65 %, shares outstanding of 52.04 M, and Return On Asset of (65.25) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Brooklyn Immunotherapeuti Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Brooklyn Immunotherapeuti's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Brooklyn Most Recent Valuation Data

Price Book
EPS Estimate Next Quarter
-29.1 M
Fiscal Year End
Enterprise Value
5.7 M
Today 0.52
Please note that Brooklyn Immunotherapeuti's price fluctuation is very risky at this time. Calculation of the real value of Brooklyn Immunotherapeuti is based on 3 months time horizon. Increasing Brooklyn Immunotherapeuti's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Brooklyn Immunotherapeutics is useful when determining the fair value of the Brooklyn stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Brooklyn Immunotherapeuti. Since Brooklyn Immunotherapeuti is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Brooklyn Stock. However, Brooklyn Immunotherapeuti's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of Brooklyn Immunotherapeutics helps investors to forecast how Brooklyn stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Brooklyn Immunotherapeuti more accurately as focusing exclusively on Brooklyn Immunotherapeuti's fundamentals will not take into account other important factors:
Estimates (1)
LowProjected EPSHigh
LowEstimated ValueHigh
LowNext ValueHigh
2 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Brooklyn Immunotherapeuti's intrinsic value based on its ongoing forecasts of Brooklyn Immunotherapeuti's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Brooklyn Immunotherapeuti's closest peers. When choosing an evaluation method for Brooklyn Immunotherapeuti, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Brooklyn Immunotherapeuti Investments

1.24 Million

Brooklyn Valuation Drivers Correlation

Many accounts on the financial statements of Brooklyn Immunotherapeuti are highly interrelated and sometimes correlated. Consequently, when conducting Brooklyn's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Brooklyn
Click cells to compare fundamentals

Brooklyn Valuation Trend

Knowing Brooklyn Immunotherapeuti's actual value is paramount for traders to make sound investment determinations. Brooklyn Immunotherapeuti's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Brooklyn Immunotherapeuti's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Brooklyn Immunotherapeuti's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Brooklyn Market Cap

Brooklyn Immunotherapeutics is number one stock in market capitalization category among related companies. Market capitalization of Biotechnology industry is currently estimated at about 101.66 Billion. Brooklyn Immunotherapeuti adds roughly 26.93 Million in market capitalization claiming only tiny portion of stocks in Biotechnology industry.
Capitalization  Total debt  Revenue  Workforce  Valuation

Brooklyn Immunotherapeuti Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Brooklyn Immunotherapeuti's current stock value. Our valuation model uses many indicators to compare Brooklyn Immunotherapeuti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brooklyn Immunotherapeuti competition to find correlations between indicators driving Brooklyn Immunotherapeuti's intrinsic value. More Info.
Brooklyn Immunotherapeutics is number one stock in price to book category among related companies. It is number one stock in price to earning category among related companies reporting about  1.93  of Price to Earning per Price to Book. Price to Earnings Ratio is likely to drop to -1.59 in 2022. Earnings Before Interest Taxes and Depreciation Amortization EBITDA is likely to drop to about (125.2 M) in 2022. Comparative valuation analysis is a catch-all model that can be used if you cannot value Brooklyn Immunotherapeuti by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Brooklyn Immunotherapeuti's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brooklyn Immunotherapeuti's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Brooklyn Immunotherapeuti's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Brooklyn Immunotherapeuti and how it compares across the competition.

About Brooklyn Immunotherapeuti Valuation

The equity valuation mechanism determines the current worth of Brooklyn Immunotherapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Brooklyn Immunotherapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Brooklyn Immunotherapeuti based exclusively on its fundamental and basic technical indicators. By analyzing Brooklyn Immunotherapeuti's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Brooklyn Immunotherapeuti's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Brooklyn Immunotherapeuti. We calculate exposure to Brooklyn Immunotherapeuti's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Brooklyn Immunotherapeuti's related companies.
Fiscal Year End
Full Time Employees
Service Category
Employer Id Number
Last ReportedProjected for 2022
Gross Profit11.1 M12.2 M
Profit Margin(0.12) (0.13) 
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York. Brooklyn Immunotherapeuti operates under Biotechnology classification in the United States and is traded on NYSEMKT Exchange. It employs 10 people.

Brooklyn Immunotherapeuti Quarterly Enterprise Value

85.54 Million

Brooklyn Immunotherapeuti Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Brooklyn Immunotherapeuti does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio6.61
Enterprise Value To Ebitda-0.19

Brooklyn Immunotherapeuti Current Valuation Indicators

Valuation refers to the process of determining the present value of Brooklyn Immunotherapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Brooklyn we look at many different elements of the entity such as Brooklyn's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Brooklyn Immunotherapeuti's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Brooklyn Immunotherapeuti's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Brooklyn Immunotherapeuti, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Brooklyn Immunotherapeuti's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Brooklyn Immunotherapeuti's worth.
Continue to Trending Equities. Note that the Brooklyn Immunotherapeuti information on this page should be used as a complementary analysis to other Brooklyn Immunotherapeuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Brooklyn Stock analysis

When running Brooklyn Immunotherapeuti price analysis, check to measure Brooklyn Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brooklyn Immunotherapeuti is operating at the current time. Most of Brooklyn Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of Brooklyn Immunotherapeuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brooklyn Immunotherapeuti's price. Additionally, you may evaluate how the addition of Brooklyn Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is Brooklyn Immunotherapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brooklyn Immunotherapeuti. If investors know Brooklyn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brooklyn Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
29.9 M
Return On Assets
Return On Equity
The market value of Brooklyn Immunotherapeuti is measured differently than its book value, which is the value of Brooklyn that is recorded on the company's balance sheet. Investors also form their own opinion of Brooklyn Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is Brooklyn Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brooklyn Immunotherapeuti's market value can be influenced by many factors that don't directly affect Brooklyn Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brooklyn Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Brooklyn Immunotherapeuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brooklyn Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.